Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT07356466 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07356466
- Sponsor
- Fujian Medical University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-04-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.